DEERFIELD, Ill. — Baxter International Inc. has appointed Andrew Hider as its next president and chief executive officer, the company announced Monday. Hider, who will also join Baxter’s board of directors, is expected to assume the role no later than Sept. 3, 2025, pending the conclusion of his current employment commitments.
Hider currently serves as CEO of ATS Corporation, a provider of advanced automation systems across sectors including life sciences, food and beverage, transportation, and energy. Since taking the helm in 2017, he has overseen significant growth at the company, with adjusted revenues nearly doubling and the stock price more than tripling on the Toronto Stock Exchange.
“Andrew is an exceptional leader with a strong track record of operational excellence, disciplined execution and innovation. We are excited that he will be Baxter’s next CEO,” said Brent Shafer, who has served as interim CEO since February and will transition to independent chair of Baxter’s board. “Andrew’s leadership at global, diversified companies underscores his ability to manage complex operations and generate value for shareholders while maintaining a focus on quality and important customer-centric missions.”
Under Hider’s leadership, ATS has expanded its global footprint to more than 65 manufacturing facilities. The company’s largest end market is now life sciences, with a focus on automation solutions for medical devices, diagnostics, pharmaceuticals, and laboratory operations — sectors closely aligned with Baxter’s core business.
“I am energized by Baxter’s mission-driven culture and strong legacy of creating medically essential products that help address patients’ and customers’ most pressing needs,” Hider said in a statement. “Baxter has undergone a significant transformation over the last few years, refocusing the company and better positioning it for the future. I look forward to partnering with the Board and working alongside my talented future colleagues to accelerate innovation, further enhance our performance and redefine healthcare delivery while driving sustainable, long-term growth.”
